Mga Batayang Estadistika
| LEI | 549300FVRPM9DRQZRG64 |
| CIK | 785161 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Encompass Health Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 6, 2025 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of June 30, 2025. |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| August 4, 2025 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 4, 2025 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| August 4, 2025 |
2025 Second Quarter Earnings Call August 5, 2025 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, future reimbursement rate |
|
| August 4, 2025 |
Encompass Health reports results for second quarter 2025 Increases full-year guidance Exhibit 99.1 Media Contact August 4, 2025 Polly Manuel, 205 969-4532 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for second quarter 2025 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospita |
|
| July 29, 2025 |
As Filed with the Securities and Exchange Commission on July 29, 2025 As Filed with the Securities and Exchange Commission on July 29, 2025 Registration No. |
|
| July 29, 2025 |
As Filed with the Securities and Exchange Commission on July 29, 2025 As Filed with the Securities and Exchange Commission on July 29, 2025 Registration No. |
|
| July 29, 2025 |
Calculation of Filing Fee Tables S-8 Encompass Health Corp Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common stock, par value $0. |
|
| July 29, 2025 |
As Filed with the Securities and Exchange Commission on July 29, 2025 As Filed with the Securities and Exchange Commission on July 29, 2025 Registration No. |
|
| July 29, 2025 |
As Filed with the Securities and Exchange Commission on July 29, 2025 As Filed with the Securities and Exchange Commission on July 29, 2025 Registration No. |
|
| June 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 25, 2025 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| June 25, 2025 |
Investor Reference Book Published: June 25, 2025 Encompass Health 2 Forward-looking statements The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, labor availability and |
|
| June 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 3, 2025 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 1, 2025 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissio |
|
| May 2, 2025 |
Exhibit 10.1 ENCOMPASS HEALTH CORPORATION 2025 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 PURPOSE 1.1. General. The purpose of the Encompass Health Corporation 2025 Omnibus Performance Incentive Plan (the “Plan”) is to promote the success, and enhance the value, of Encompass Health Corporation (the “Company”) and its subsidiaries, by linking the personal interests of their employees, officers an |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| May 1, 2025 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of March 31, 2025. |
|
| April 24, 2025 |
2025 First Quarter Earnings Call April 25, 2025 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, labor availability and cos |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 24, 2025 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| April 24, 2025 |
Encompass Health announces promotion of Patrick Tuer to newly established COO position Exhibit 99.3 Media contact Polly Manuel | 205 970-5912 [email protected] Investor Relations contact Mark Miller | 205-970-5860 [email protected] Encompass Health announces promotion of Patrick Tuer to newly established COO position BIRMINGHAM, Ala., April 24, 2025 – Encompass Health Corp. (NYSE: EHC) today announced the promotion of Patrick Tuer from group president to the ne |
|
| April 24, 2025 |
Encompass Health reports results for first quarter 2025 Increases full-year guidance Exhibit 99.1 Media Contact April 24, 2025 Polly Manuel, 205 969-4532 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for first quarter 2025 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospital |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| February 28, 2025 |
Encompass Health Corporation Sixth Amended and Restated Change in Control Benefits Plan.+ Exhibit 10.3 ENCOMPASS HEALTH CORPORATION SIXTH AMENDED AND RESTATED CHANGE IN CONTROL BENEFITS PLAN Encompass Health Corporation, a Delaware corporation (the “Company”), has adopted the Encompass Health Corporation Sixth Amended and Restated Change in Control Benefits Plan (the “Plan”) for the benefit of certain Participant employees of the Company and its subsidiaries, on the terms and condition |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| February 28, 2025 |
Subsidiaries of Encompass Health Corporation. Exhibit 21.1 Subsidiary Name Jurisdiction of Incorporation DBA AnMed Encompass Health Rehabilitation Hospital, LLC SC AnMed Health Rehabilitation Hospital Central Arkansas Rehabilitation Associates, L.P. DE CHI St. Vincent Hot Springs Rehabilitation Hospital, a partner of Encompass Health CHI St. Vincent Sherwood Rehabilitation Hospital, a partner of Encompass Health Central Louisiana Rehab Associ |
|
| February 28, 2025 |
Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of December 31, 2024. |
|
| February 28, 2025 |
Encompass Health Corporation Sixth Amended and Restated Executive Severance Plan.+ Exhibit 10.6 ENCOMPASS HEALTH CORPORATION SIXTH AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN Encompass Health Corporation, a Delaware corporation (the “Company”), has adopted the Encompass Health Corporation Sixth Amended and Restated Executive Severance Plan, to be effective as of October 9, 2018 (the “Plan”), for the benefit of certain employees of the Company and its subsidiaries, on the terms |
|
| February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 19, 2025 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| February 10, 2025 |
JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Encompass Health Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. |
|
| February 6, 2025 |
2024 Fourth Quarter Earnings Call February 7, 2025 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, labor availability and |
|
| February 6, 2025 |
Encompass Health reports results for fourth quarter 2024 and issues 2025 guidance Exhibit 99.1 Media Contact February 6, 2025 Polly Manuel, 205 969-4532 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for fourth quarter 2024 and issues 2025 guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals |
|
| February 6, 2025 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 6, 2025 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| November 14, 2024 |
SC 13G/A 1 tm2428293d6sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUS |
|
| November 8, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* Encompass Health Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropri |
|
| November 8, 2024 |
EHC / Encompass Health Corporation / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| November 8, 2024 |
Invesco Joint Filing Agreement JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (l) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of the attached Schedule 13G, and any and all amendments thereto, and expressly authorize Invesco Ltd. |
|
| November 8, 2024 |
EX-99 2 Rule13DJointFilingAgreement.htm JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Encompass Health Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13 |
|
| November 1, 2024 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of September 30, 2024. |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| October 28, 2024 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 28, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| October 28, 2024 |
2024 Third Quarter Earnings Call October 29, 2024 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, labor availability and c |
|
| October 28, 2024 |
Encompass Health reports results for third quarter 2024 Increases full-year guidance Exhibit 99.1 Media Contact October 28, 2024 Polly Manuel, 205 969-4532 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for third quarter 2024 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospit |
|
| August 6, 2024 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of June 30, 2024. |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| August 5, 2024 |
2024 Second Quarter Earnings Call August 6, 2024 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, labor availability and co |
|
| August 5, 2024 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| August 5, 2024 |
Encompass Health reports results for second quarter 2024 Increases full-year guidance Exhibit 99.1 Media Contact August 5, 2024 Polly Manuel, 205 969-4532 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for second quarter 2024 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospita |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 21, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| June 21, 2024 |
Investor Reference Book Published: June 21, 2024 Encompass Health 2 Forward-looking statements The information contained in this Investor Reference Book includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, value driver |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 29, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| May 6, 2024 |
Regulation FD Disclosure, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 2, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissio |
|
| May 2, 2024 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of March 31, 2024. |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| April 24, 2024 |
Encompass Health reports results for first quarter 2024 Increases full-year guidance Exhibit 99.1 Media Contact April 24, 2024 Kennedi Spurling, 205 970-5912 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for first quarter 2024 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation |
|
| April 24, 2024 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 24, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| April 24, 2024 |
2024 First Quarter Earnings Call April 25, 2024 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook, guidance and growth targets, value drivers, labor avail |
|
| April 11, 2024 |
Main Post Office, P.O. Box 751 www.asyousow.org Berkeley, CA 94704 BUILDING A SAFE, JUST, AND SUSTAINABLE WORLD SINCE 1992 Notice of Exempt Solicitation Pursuant to Rule 14a-103 Name of the Registrant: Encompas Health Corp. (EHC) Name of persons relying on exemption: As You Sow™ Address of persons relying on exemption: Main Post Office, P.O. Box 751, Berkeley, CA 94704 Written materials are submit |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| March 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 11, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| March 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 27, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| February 28, 2024 |
Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of December 31, 2023. |
|
| February 28, 2024 |
Subsidiaries of Encompass Health Corporation. Exhibit 21.1 Subsidiary Name Jurisdiction of Incorporation DBA AnMed Encompass Health Rehabilitation Hospital, LLC SC AnMed Health Rehabilitation Hospital Central Arkansas Rehabilitation Associates, L.P. DE CHI St. Vincent Hot Springs Rehabilitation Hospital, a partner of Encompass Health CHI St. Vincent Sherwood Rehabilitation Hospital, a partner of Encompass Health CMS Rehab of WF, L.P. DE Encom |
|
| February 28, 2024 |
Encompass Health Corporation Compensation Recoupment Policy. Exhibit 97 Encompass Health Corporation Compensation Recoupment Policy (adopted by the Board of Directors on July 20, 2023) Except as noted below, the terms of this Policy, as may be amended from time to time, apply to each officer participating in one or both of the senior management bonus plan and the long-term incentive plan, as each may be amended from time to time, of Encompass Health Corporation (the “Company”). |
|
| February 28, 2024 |
Encompass Health Corporation Insider Trading Policy. Exhibit 19 ENCOMPASS HEALTH CORPORATION INSIDER TRADING POLICY Amended and Restated as of October 19, 20231 Purpose. |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 27, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| February 12, 2024 |
SC 13G 1 tm245766d12sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Num |
|
| February 12, 2024 |
EHC / Encompass Health Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0005-encompasshealthcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Encompass Health Corp Title of Class of Securities: Common Stock CUSIP Number: 29261A100 Date of Event Which Requires Filing of this Statement: January 31, 2024 Check the appropriate box to des |
|
| February 12, 2024 |
EHC / Encompass Health Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Encompass Health Corp Title of Class of Securities: Common Stock CUSIP Number: 29261A100 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 8, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| February 7, 2024 |
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 ourth Quarter a l February 8, 2024 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business out |
|
| February 7, 2024 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 7, 2024 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| February 7, 2024 |
Encompass Health reports results for fourth quarter 2023 and issues 2024 guidance Exhibit 99.1 Media Contact February 7, 2024 Danielle Hall, 205 970-5912 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for fourth quarter 2023 and issues 2024 guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospita |
|
| November 27, 2023 |
Encompass Health appoints Ted Christie to its board of directors Exhibit 99.1 Media Contact Danielle Hall | 205-970-5912 [email protected] Investor Relations Contact Mark Miller | 205-970-5860 [email protected] Encompass Health appoints Ted Christie to its board of directors BIRMINGHAM, Ala., Nov. 27, 2023 - Encompass Health Corporation (NYSE: EHC) today announced the appointment of Edward M. Christie III to its board of directors. |
|
| November 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 21, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| November 1, 2023 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of September 30, 2023. |
|
| October 31, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Encompass Health Corporation* (Exact Name of Registrant as Specified in its Charter) * See Table of Additional Registrants in the Registration Statement Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to Be Carried Forward Newly Registered Securities Fees to Be Paid Equity Common Stock of Encompass Health Corporation, par value $0. |
|
| October 31, 2023 |
As filed with the Securities and Exchange Commission on October 31, 2023 As filed with the Securities and Exchange Commission on October 31, 2023 Registration No. |
|
| October 31, 2023 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| October 31, 2023 |
Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, Exhibit 25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) [] COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) Na |
|
| October 26, 2023 |
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 Third Quarter a l October 27, 2023 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business out |
|
| October 26, 2023 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 26, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| October 26, 2023 |
Encompass Health reports results for third quarter 2023 Updates full-year guidance Exhibit 99.1 Media Contact October 26, 2023 Danielle Hall, 205 970-5912 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for third quarter 2023 Updates full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospit |
|
| September 27, 2023 |
2023 Investor Day Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook and guidance, labor availability and costs, legislative and regulatory developments, strategy, capital expenditures, acquisition and other development activities, such as the de novo pipeline, costs, growth and timelines, operational initiatives, dividend strategies, leverage, repurchases of securities, effective tax rates, financial performance, financial assumptions, business model, balance sheet and cash flow plans, and addressable market size. |
|
| September 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 27, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Co |
|
| August 4, 2023 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes as of June 30, 2023. |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| August 1, 2023 |
q22023earningsslidesfin Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 Second Quarter a l August 2, 2023 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, inc |
|
| August 1, 2023 |
Encompass Health reports results for second quarter 2023 Increases full-year guidance Exhibit 99.1 Media Contact August 1, 2023 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for second quarter 2023 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospita |
|
| August 1, 2023 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 1, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| July 25, 2023 |
Description of the Encompass Health Corporation Compensation Recoupment Policy. Exhibit 10.1 Encompass Health Corporation Compensation Recoupment Policy (adopted by the Board of Directors on July 20, 2023) Except as noted below, the terms of this Policy, as may be amended from time to time, apply to each officer participating in one or both of the senior management bonus plan and the long-term incentive plan, as each may be amended from time to time, of Encompass Health Corpo |
|
| July 25, 2023 |
Encompass Health Corporation Sixth Amended and Restated Change in Control Benefits Plan. Exhibit 10.2 ENCOMPASS HEALTH CORPORATION SIXTH AMENDED AND RESTATED CHANGE IN CONTROL BENEFITS PLAN Encompass Health Corporation, a Delaware corporation (the “Company”), has adopted the Encompass Health Corporation Sixth Amended and Restated Change in Control Benefits Plan (the “Plan”) for the benefit of certain Participant employees of the Company and its subsidiaries, on the terms and condition |
|
| July 25, 2023 |
Encompass Health Corporation Sixth Amended and Restated Executive Severance Plan. Exhibit 10.3 ENCOMPASS HEALTH CORPORATION SIXTH AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN Encompass Health Corporation, a Delaware corporation (the “Company”), has adopted the Encompass Health Corporation Sixth Amended and Restated Executive Severance Plan, to be effective as of October 9, 2018 (the “Plan”), for the benefit of certain employees of the Company and its subsidiaries, on the terms |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 20, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 31, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| May 31, 2023 |
ehcmay312023investorrefe Investor Reference Book Published: May 31, 2023 Encompass Health 2 Forward-looking statements The information contained in this Investor Reference Book includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outlook and guidance, labo |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| May 8, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 4, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissio |
|
| May 3, 2023 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| April 27, 2023 |
Encompass Health reports results for first quarter 2023 Increases full-year guidance Exhibit 99.1 Media Contact April 27, 2023 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for first quarter 2023 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospital |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| April 27, 2023 |
ehcq12023earningsslides Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 irst Quarter a l April 28, 2023 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, inclu |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| March 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 14, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 22, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| February 27, 2023 |
First Amendment to the Encompass Health Corporation Nonqualified Retirement Plan.+ Exhibit 10.8.2 FIRST AMENDMENT TO THE ENCOMPASS HEALTH CORPORATION NONQUALIFIED 401(k) PLAN (as Amended and Restated Effective January 2, 2018) WHEREAS, Encompass Health Corporation (the “Company”) established the Encompass Health Corporation Nonqualified 401(k) Plan, which was most recently amended and restated effective January 2, 2018 (the “Plan”); and WHEREAS, pursuant to Section 10.1 of the P |
|
| February 27, 2023 |
Subsidiaries of Encompass Health Corporation. Exhibit 21.1 Subsidiary Name Jurisdiction of Incorporation DBA Advanced Homecare Holdings, Inc. DE AnMed Encompass Health Rehabilitation Hospital, LLC SC AnMed Health Rehabilitation Hospital Central Arkansas Rehabilitation Associates, L.P. DE CHI St. Vincent Hot Springs Rehabilitation Hospital, a partner of Encompass Health CHI St. Vincent Sherwood Rehabilitation Hospital, a partner of Encompass H |
|
| February 27, 2023 |
Encompass Health Corporation Fifth Amended and Restated Change in Control Benefits Plan Exhibit 10.3 ENCOMPASS HEALTH CORPORATION FIFTH AMENDED AND RESTATED CHANGE IN CONTROL BENEFITS PLAN Encompass Health Corporation, a Delaware corporation (the “Company”), has adopted the Encompass Health Corporation Fifth Amended and Restated Change in Control Benefits Plan (the “Plan”) for the benefit of certain Participant employees of the Company and its subsidiaries, on the terms and condition |
|
| February 27, 2023 |
Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant The entities listed in the table below are either direct or indirect subsidiaries of Encompass Health Corporation, and they each, jointly and severally, guarantee the payment of each series of unsecured senior notes issued by Encompass Health Corporatio |
|
| February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 8, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| February 9, 2023 |
EHC / Encompass Health Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0815-encompasshealthcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Encompass Health Corp. Title of Class of Securities: Common Stock CUSIP Number: 29261A100 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to d |
|
| February 7, 2023 |
Encompass Health reports results for fourth quarter 2022 and issues full-year 2023 guidance Exhibit 99.1 Media Contact February 7, 2023 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for fourth quarter 2022 and issues full-year 2023 guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation |
|
| February 7, 2023 |
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter ourth Quarter a l February 8, 2023 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the business outl |
|
| February 7, 2023 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 7, 2023 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| February 6, 2023 |
EHC / Encompass Health Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| December 13, 2022 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF ENCOMPASS HEALTH CORPORATION (a Delaware corporation) Amended and Restated Bylaws of Encompass Health Corporation, December 8, 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Location 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholder |
|
| December 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 8, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 14, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| November 2, 2022 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| October 26, 2022 |
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter Third Quarter a l October 27, 2022 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the business outl |
|
| October 26, 2022 |
Encompass Health reports results for third quarter 2022 Exhibit 99.1 Media Contact October 26, 2022 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for third quarter 2022 BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, tod |
|
| October 26, 2022 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 26, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| October 13, 2022 |
EXHIBIT 10.1 EXECUTION VERSION SIXTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 7, 2022 among ENCOMPASS HEALTH CORPORATION, The Lenders Party Hereto, BARCLAYS BANK PLC, as Administrative Agent and Collateral Agent, CITIGROUP GLOBAL MARKETS INC., as Syndication Agent, and BANK OF AMERICA, N.A., GOLDMAN SACHS BANK USA, and MORGAN STANLEY SENIOR FUNDING, INC., as Co-Documentation Agent |
|
| October 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 7, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commi |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| August 4, 2022 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| August 1, 2022 |
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter Second Quarter a l August 2, 2022 Supplemental information Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the effects of the |
|
| August 1, 2022 |
Exhibit 99.1 Media Contact August 1, 2022 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for second quarter 2022 BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, toda |
|
| August 1, 2022 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 1, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| July 7, 2022 |
Exhibit 2.4 Execution Version EMPLOYEE MATTERS AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. DATED AS OF JUNE 30, 2022 W/4282771 TABLE OF CONTENTS Page Article I DEFINITIONS 1 Section 1.01. Definitions 1 Section 1.02. Interpretation 7 Article II GENERAL PRINCIPLES FOR ALLOCATION OF LIABILITIES 7 Section 2.01. General Principles 7 Section 2.02. Service Credit Recognized by |
|
| July 7, 2022 |
Exhibit 2.2 TRANSITION SERVICES AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. Dated as of June 30, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 ARTICLE II SERVICES, DURATION AND SERVICES MANAGERS 4 2.1 Services 4 2.2 Duration of Services 4 2.3 Additional Unspecified Services 5 2.4 Services Not Included 6 2.5 Transitional Nature of Services 6 2.6 Transition Services |
|
| July 7, 2022 |
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On July 1, 2022, Encompass Health Corporation (the ?Company?, ?Encompass Health?, ?we?, ?our? and ?us?) completed the previously announced separation of its home health and hospice business, into a separate, independent publicly traded company, Enhabit, Inc. (?Enhabit?). The separation was structured as a spin off (the ?S |
|
| July 7, 2022 |
Exhibit 2.1 EXECUTION VERSION SEPARATION AND DISTRIBUTION AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. Dated as of June 30, 2022 TABLE OF CONTENTS Page SCHEDULES iv EXHIBITS iv ARTICLE I DEFINITIONS 2 ARTICLE II THE SEPARATION 15 2.1 Transfer of Assets and Assumption of Liabilities 15 2.2 Enhabit Assets; Encompass Assets 18 2.3 Enhabit Liabilities; Encompass Liabilities |
|
| July 7, 2022 |
Exhibit 2.3 TAX MATTERS AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION and ENHABIT, INC. DATED AS OF JUNE 30, 2022 TABLE OF CONTENTS Page Section 1. Definition of Terms 2 Section 2. Allocation of Tax Liabilities 10 Section 2.01 General Rule 10 Section 2.02 Allocation of Federal Income Tax and Federal Other Tax 11 Section 2.03 Allocation of State Income and State Other Taxes 11 Section 2.04 |
|
| July 7, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 30, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| June 21, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 17, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| June 21, 2022 |
INFORMATION STATEMENT ENHABIT, INC. TABLE OF CONTENTS Exhibit 99.1 ? June 21, 2022 Dear Encompass Health Corporation Stockholder: We previously announced plans to separate our home health and hospice business (the ?Enhabit Business?) into an independent, publicly traded company, which we expect to list on the New York Stock Exchange under the trading symbol ?EHAB? when the separation is complete. The separation will occur through a |
|
| June 13, 2022 |
Enhabit Home Health & Hospice June 2022 Enhabit Home Health & Hospice 2 Disclaimer This presentation and the accompanying oral presentation (this ?Presentation?) has been prepared by Enhabit, Inc. |
|
| June 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 13, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| June 7, 2022 |
Execution Version CREDIT AGREEMENT dated as of June 1, 2022 among ENHABIT, INC., as the Borrower, THE LENDERS PARTY HERETO, WELLS FARGO BANK, NATIONAL ASSOCIATION as Administrative Agent, and WELLS FARGO BANK, NATIONAL ASSOCIATION as Collateral Agent WELLS FARGO SECURITIES, LLC, BANK OF AMERICA, N.A., TRUIST SECURITIES, INC., CITIBANK, N.A. and JPMORGAN CHASE BANK, N.A. as Joint Lead Arrangers and |
|
| June 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 7, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| June 7, 2022 |
Exhibit 99.1 Media Contact June 7, 2022 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health issues full-year 2022 guidance for Encompass Health and Enhabit BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC) (?Encompass Health? or the ?Company?), today issued separate full-year 202 |
|
| June 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 1, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| June 7, 2022 |
Encompass Health - 2022 Guidance for Encompass Health and Enhabit June 7, 2022 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health and Enhabit?s current outlooks, views and plans with respect to future events, including the timing and effects, such as the tax-free treatments, the incremental cost |
|
| June 7, 2022 |
Execution Version SECOND AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT This Second Amendment to Fifth amended and restated Credit Agreement, dated as of June 2, 2022 (this ?Amendment?), is among ENCOMPASS HEALTH CORPORATION (the ?Borrower?), the affiliates of the Borrower party to this Amendment as Guarantors, the several financial institutions party to this Amendment as Lenders, and BARCLAYS BANK PLC, as administrative agent (in such capacity, the ?Administrative Agent?) and collateral agent (in such capacity, the ?Collateral Agent?) for the Lenders. |
|
| May 9, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 5, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissio |
|
| May 3, 2022 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| April 27, 2022 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| April 27, 2022 |
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the timing and effects, such as the tax-free treatment and the incremental co |
|
| April 27, 2022 |
Exhibit 99.1 Media Contact April 27, 2022 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for first quarter 2022 BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care |
|
| April 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 30, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| March 31, 2022 |
Exhibit 99.1 Media Contact Erin Wendel-Ritter | 205 970-5912 [email protected] Investor Relations Contact Mark Miller | 205 970-5860 [email protected] Encompass Health appoints Kevin O’Connor to its Board of Directors Announces retirement of five directors BIRMINGHAM, Ala., Mar. 30, 2022 - Encompass Health Corporation (NYSE: EHC) today announced the appointment o |
|
| March 16, 2022 |
Barclays Healthcare Conference Doug Coltharp Executive Vice President and Chief Financial Officer March 16, 2022 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the timing and effects, such as the tax-free treatment a |
|
| March 16, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 16, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| February 25, 2022 |
Subsidiaries of Encompass Health Corporation. Exhibit 21.1 Subsidiary Name Jurisdiction of Incorporation DBA A&B Home Health Solutions, LLC DE Encompass Health Home Health Abba Home Health, L.P. TX Encompass Health Home Health Encompass Health Hospice Advanced Homecare Management, Inc. DE Encompass Health Home Health and Hospice AHM Action Home Health, LP TX Encompass Health Home Health AnMed Encompass Health Rehabilitation Hospital, LLC SC A |
|
| February 25, 2022 |
Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant The entities listed in the table below are either direct or indirect subsidiaries of Encompass Health Corporation, and they each, jointly and severally, guarantee the payment of each series of unsecured senior notes issued by Encompass Health Corporatio |
|
| February 10, 2022 |
EHC / Encompass Health Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Encompass Health Corp. Title of Class of Securities: Common Stock CUSIP Number: 29261A100 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 4, 2022 |
EHC / Encompass Health Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 1, 2022 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 1, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| February 1, 2022 |
Earnings Call February 2, 2022 Supplemental information 2021 Fourth Quarter Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the timing and effects, such as the tax-free treatment and the incremental |
|
| February 1, 2022 |
Press release of Encompass Health Corporation, dated Exhibit 99.1 Media Contact February 1, 2022 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for fourth quarter 2021 and issues full-year 2022 guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, offering facil |
|
| January 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 24, 2022 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| January 25, 2022 |
Exhibit 4.5 EXECUTION VERSION TWELFTH SUPPLEMENTAL INDENTURE ENCOMPASS HEALTH CORPORATION WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Dated as of January 24, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS SECTION 1.01. Definitions 2 ARTICLE II AMENDMENT OF EACH EXISTING INDENTURE SECTION 2.01. Amendment of Section 5.06 of each Existing Indenture 3 SECTION 2.02. Amendment of Article I of |
|
| December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 15, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| December 17, 2021 |
Exhibit 4.3 EXECUTION VERSION ELEVENTH SUPPLEMENTAL INDENTURE ENCOMPASS HEALTH CORPORATION WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Dated as of December 15, 2021 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS SECTION 1.01. Definitions 2 ARTICLE II Amendment of the Existing Indenture SECTION 2.01. Amendment of Section 5.06 of the Existing Indenture 3 SECTION 2.02. Amendment of Article I of |
|
| December 9, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 9, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| December 9, 2021 |
Encompass Health Corporation Announces Consent Solicitation EXHIBIT 99.1 Media contact: Casey Winger | 205-970-5912 [email protected] Investor Relations contact: Mark Miller | 205-970-5860 [email protected] Encompass Health Corporation Announces Consent Solicitation BIRMINGHAM, Ala., December 9, 2021 ? Encompass Health Corporation (?Encompass Health? or the ?Company?) (NYSE: EHC), a national leader in integrated healthcare, off |
|
| November 2, 2021 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| October 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 21, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Co |
|
| October 27, 2021 |
Exhibit 99.1 Media Contact October 27, 2021 Casey Winger, 205 447-6410 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] Encompass Health reports results for third quarter 2021 Revises full-year guidance for 2021 BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, offering facil |
|
| October 27, 2021 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 27, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| October 27, 2021 |
Earnings Call October 28, 2021 Supplemental information Third Quarter Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the ongoing strategic review and its impact on the business model, outlook and g |
|
| September 7, 2021 |
Encompass Health appoints Christopher Reidy to its Board of Directors EXHIBIT 99.1 Media Contact: Casey Winger| 205 447-6410 [email protected] Encompass Health appoints Christopher Reidy to its Board of Directors BIRMINGHAM, Ala., Sept. 7, 2021 ? Encompass Health Corporation (NYSE: EHC) today announced the appointment of Christopher R. Reidy to the Encompass Health board of directors, effective October 1, 2021. This appointment will expand the Encom |
|
| September 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 31, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commi |
|
| August 3, 2021 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| August 3, 2021 |
Exhibit 10.1 [Encompass Health Letterhead] BY EMAIL June 21, 2021 Barbara A. Jacobsmeyer Re: New Position and Compensation Adjustment Dear Barb: As we have discussed, we are pleased to appoint you as Chief Executive Officer, Home Health and Hospice, effective as of June 21, 2021 (the ?Effective Date?). You will continue to report directly to the President and Chief Executive Officer of the Company |
|
| August 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| July 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 28, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| July 27, 2021 |
July 28, 2021 Supplemental information Second Quarter Earnings Call Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the ongoing strategic review and its impact on the business model, outlook and gui |
|
| July 27, 2021 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| July 27, 2021 |
Exhibit 99.1 Media Contact July 27, 2021 Casey Lassiter, 205 447-6410 [email protected] Investor Relations Contact Crissy Carlisle, 205 970-5860 [email protected] Encompass Health reports results for second quarter 2021 Increases full-year guidance for 2021 BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, of |
|
| June 21, 2021 |
Encompass Health Appoints Barbara A. Jacobsmeyer as CEO of Home Health and Hospice Business EXHIBIT 99.1 Media Contact: Casey Winger| 205.970.5912 [email protected] Investor Relations Contact: Crissy Carlisle | 205.970.5860 [email protected] Encompass Health Appoints Barbara A. Jacobsmeyer as CEO of Home Health and Hospice Business BIRMINGHAM, Ala., - June 21, 2021 ? Encompass Health Corp. (NYSE: EHC) today announced that Barbara A. Jacobsmeyer, Preside |
|
| June 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 18, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| May 11, 2021 |
Regulation FD Disclosure, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 6, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissio |
|
| May 4, 2021 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| May 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| April 27, 2021 |
Exhibit 99.1 Media Contact April 27, 2021 Casey Lassiter, 205 447-6410 [email protected] Investor Relations Contact Crissy Carlisle, 205 970-5860 [email protected] Encompass Health reports results for first quarter 2021 and increases full-year 2021 guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), a national leader in integrated healthcare, of |
|
| April 27, 2021 |
April 28, 2021 Supplemental information First Quarter Earnings Call Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health?s current outlook, views and plans with respect to future events, including the ongoing strategic review and its impact on the business model, outlook and gui |
|
| April 27, 2021 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| April 2, 2021 |
EXHIBIT 99.1 Encompass Health Contacts: Media: Casey Lassiter| 205 970-5912 [email protected] Investor Relations: Crissy Carlisle | 205 970-5860 [email protected] Encompass Health Announces Leadership Transition for Home Health and Hospice Business April Anthony to Step Down as CEO BIRMINGHAM, Ala. ? April 2, 2021 ? Encompass Health Corp. (NYSE: EHC) today announ |
|
| April 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 29, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commis |
|
| March 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| March 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 9, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| March 9, 2021 |
ehcq42020investorreferen Investor Reference Book 2020 Encompass Health 2 Forward-looking statements The information contained in this Investor Reference Book includes certain estimates, projections and other forward- looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the ongoing strategic review and its impact on the busine |
|
| February 26, 2021 |
Subsidiaries of Encompass Health Corporation. Exhibit 21.1 Subsidiary Name Jurisdiction of Incorporation DBA A&B Home Health Solutions, LLC DE Encompass Health Home Health Abba Home Health, L.P. TX Encompass Health Home Health Encompass Health Home Health & Hospice Encompass Health Hospice Advanced Homecare Management, Inc. DE Encompass Health Home Health & Hospice Encompass Health AHM Action Home Health, LP TX AnMed Encompass Health Rehabili |
|
| February 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| February 26, 2021 |
Exhibit 22.1 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant The entities listed in the table below are either direct or indirect subsidiaries of Encompass Health Corporation, and they each, jointly and severally, guarantee the payment of each series of unsecured senior notes issued by Encompass Health Corporatio |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) 12/31/2020 (Date of Event Which |
|
| February 10, 2021 |
SC 13G/A 1 tv0770-encompasshealthcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Encompass Health Corp. Title of Class of Securities: Common Stock CUSIP Number: 29261A100 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to de |
|
| February 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| January 26, 2021 |
EX-99.1 2 ehcearningsrelease123120.htm EX-99.1 Exhibit 99.1 Media Contact January 26, 2021 Casey Lassiter, 205 447-6410 [email protected] Investor Relations Contact Crissy Carlisle, 205 970-5860 [email protected] Encompass Health reports results for fourth quarter 2020 and issues full-year 2021 guidance and longer term growth targets BIRMINGHAM, Ala. - Encompass |
|
| January 26, 2021 |
ehcq42020earningsslides January 27, 2021 Supplemental information Fourth Quarter Earnings Call Encompass Health 2 The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the ongoing strategic review and its impact on the busi |
|
| January 26, 2021 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 26, 2021 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| December 9, 2020 |
Encompass Health Exploring Strategic Alternatives for Home Health and Hospice Business EXHIBIT 99.1 Media Contact: Casey Lassiter | 205-447-6410 [email protected] Investor Relations Contact: Crissy Carlisle | 205-970-5860 [email protected] Encompass Health Exploring Strategic Alternatives for Home Health and Hospice Business BIRMINGHAM, Ala. — December 9, 2020 — Encompass Health Corp. (NYSE: EHC) today announced that it is exploring strategic alter |
|
| December 9, 2020 |
Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 9, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| November 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 13, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| November 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| November 2, 2020 |
Exhibit 10.1 ENCOMPASS HEALTH CORPORATION FIFTH AMENDED AND RESTATED CHANGE IN CONTROL BENEFITS PLAN Encompass Health Corporation, a Delaware corporation (the “Company”), has adopted the Encompass Health Corporation Fifth Amended and Restated Change in Control Benefits Plan (the “Plan”) for the benefit of certain Participant employees of the Company and its subsidiaries, on the terms and condition |
|
| November 2, 2020 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| October 28, 2020 |
ehcq32020earningsslides Third Quarter Earnings Call October 29, 2020 Supplemental information Forward-looking statements The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the COVID-19 pandemic and its effects, legislati |
|
| October 28, 2020 |
Encompass Health reports results for third quarter 2020 Exhibit 99.1 Media Contact October 28, 2020 Casey Lassiter, 205 447-6410 [email protected] Investor Relations Contact Crissy Carlisle, 205 970-5860 [email protected] Encompass Health reports results for third quarter 2020 BIRMINGHAM, Ala. - Encompass Health Corp. (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patie |
|
| October 28, 2020 |
Regulation FD Disclosure, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 28, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Comm |
|
| October 5, 2020 |
Consent of Snell & Wilmer L.L.P. (included in Exhibit 5.4). EX-5.4 Exhibit 5.4 [Letterhead of Snell & Wilmer L.L.P.] October 5, 2020 Encompass Health Corporation 9001 Liberty Parkway Birmingham, Alabama 35242 Ladies and Gentlemen: We have acted as special counsel to WellCare, Inc., a New Mexico corporation (“WellCare”) and a subsidiary of Encompass Health Corporation, a Delaware corporation (the “Company”), in connection with the guarantee by WellCare and |
|
| October 5, 2020 |
EX-1.1 Exhibit 1.1 Execution Version $400,000,000 ENCOMPASS HEALTH CORPORATION 4.625% Senior Notes due 2031 UNDERWRITING AGREEMENT New York, New York September 30, 2020 Truist Securities, Inc. as Representative of the Several Underwriters listed in Schedule 1 hereto and Barclays Capital Inc. BofA Securities, Inc. Citigroup Global Markets Inc. Goldman Sachs & Co. LLC J.P. Morgan Securities LLC Morg |
|
| October 5, 2020 |
Consent of Hawley Troxell Ennis & Hawley LLP (included in Exhibit 5.3). EX-5.3 Exhibit 5.3 [Letterhead of Hawley Troxell Ennis & Hawley LLP] October 5, 2020 Encompass Health Corporation 9001 Liberty Parkway Birmingham, Alabama 35242 Ladies and Gentlemen: We have acted as special counsel to each of the Opinion Guarantors (as defined below), each Opinion Guarantor being a direct or indirect subsidiary of Encompass Health Corporation, a Delaware corporation (the “Company |
|
| October 5, 2020 |
EX-4.2 Exhibit 4.2 TENTH SUPPLEMENTAL INDENTURE ENCOMPASS HEALTH CORPORATION 4.625% SENIOR NOTES DUE 2031 WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Dated as of October 5, 2020 TABLE OF CONTENTS Page ARTICLE I Establishment of New Series SECTION 1.01. Establishment of New Series 1 ARTICLE II Definitions SECTION 2.01. Definitions 2 ARTICLE III The Securities SECTION 3.01. Form 22 ARTICLE IV |
|
| October 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2020 Encompass Health Corporation (Exact Name of Registrant as specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commission File Number) (IRS Employer Identification No. |
|
| October 1, 2020 |
424B5 Table of Contents Filed pursuant to Rule 424(b)(5) Registration Statement No. |
|
| September 30, 2020 |
SUBJECT TO COMPLETION DATED SEPTEMBER 30, 2020 Form 424(b)(5) Table of Contents Filed pursuant to Rule 424(b)(5) Registration No. |
|
| September 30, 2020 |
FWP Free Writing Prospectus Filed Pursuant to Rule 433 Registration Statement No. 333- 248942 September 30, 2020 $400,000,000 Encompass Health Corporation 4.625% Senior Notes due 2031 Pricing Term Sheet dated September 30, 2020 Issuer: Encompass Health Corporation Size: $400,000,000 Maturity: April 1, 2031 Coupon: 4.625% Offering Price: 100.00% of face amount plus accrued interest from October 5, |
|
| September 21, 2020 |
EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A National Banking |
|
| September 21, 2020 |
S-3ASR 1 d57512ds3asr.htm FORM S-3ASR Table of Contents As filed with the Securities and Exchange Commission on September 21, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Encompass Health Corporation* (Exact Name of Registrant as Specified in its Charter) Delaware 63-0860407 (Stat |
|
| September 9, 2020 |
september2020bairdconfer Inpatient Rehabilitation - Patient Census Information • Inpatient rehabilitation patient census reached a low point on April 12, 2020 (Easter Weekend). |
|
| September 9, 2020 |
Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 9, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Com |
|
| August 27, 2020 |
bargraphsirfhhahospice08 Inpatient Rehabilitation – Patient Census Information • Inpatient rehabilitation patient census reached a low point on April 12, 2020 (Easter Weekend). |
|
| August 27, 2020 |
Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 27, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commi |
|
| August 19, 2020 |
Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 19, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commi |
|
| August 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 13, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commi |
|
| August 13, 2020 |
ehcq22020investorreferen Investor Reference Book Post Q2 2020 earnings release Last updated August 13, 2020 HealthSouth is a leading provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 34 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. |
|
| August 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Encompass Health Corp (Name of Issuer) Common Stock (Title of Class of Securities) 29261A100 (CUSIP Number) July 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| July 31, 2020 |
List of Subsidiary Guarantors. Exhibit 22 List of Subsidiary Guarantors The following direct and indirect subsidiaries of Encompass Health Corporation guarantee each series of its senior unsecured notes. |
|
| July 31, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware 63-0860407 (State or Other Jurisdiction of Incorporation or Organization) (I. |
|
| July 27, 2020 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| July 27, 2020 |
Encompass Health reports results for second quarter 2020 Exhibit 99.1 Media Contact July 27, 2020 Casey Lassiter, 205 447-6410 [email protected] Investor Relations Contact Crissy Carlisle, 205 970-5860 [email protected] Encompass Health reports results for second quarter 2020 BIRMINGHAM, Ala. - Encompass Health Corp. (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient |
|
| July 27, 2020 |
ehcq22020earningsslides0 Second Quarter Earnings Call July 28, 2020 Supplemental information Forward-looking statements The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect Encompass Health’s current outlook, views and plans with respect to future events, including the COVID-19 pandemic and its effects, legislativ |
|
| June 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 22, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commiss |
|
| June 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 9, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| June 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 2, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| June 2, 2020 |
ehcq12020investorreferen Investor Reference Book Post Q1 2020 earnings release Last updated June 2, 2020 HealthSouth is a leading provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 34 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. |
|
| May 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2020 Encompass Health Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-10315 63-0860407 (Commissi |
|
| May 15, 2020 |
EX-1.1 Exhibit 1.1 $600,000,000 ENCOMPASS HEALTH CORPORATION 4.500% Senior Notes due 2028 4.750% Senior Notes due 2030 UNDERWRITING AGREEMENT New York, New York May 12, 2020 BofA Securities, Inc. as Representative of the Several Underwriters listed in Schedule 1 hereto and Barclays Capital Inc. Citigroup Global Markets Inc. Goldman Sachs & Co. LLC J.P. Morgan Securities LLC Morgan Stanley & Co. LL |
